Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 405.67 | 559.73 | 667.59 | 467.67 |
Depreciation/ Depletion | 51.81 | 46.46 | 38.26 | 31.22 |
Non- Cash Items | -36.46 | -15.12 | 2.38 | 5.26 |
Changesin Working Capital | -62.54 | -140.16 | -378.22 | -121.61 |
Cashfrom Operating Activities | 358.48 | 450.91 | 330.00 | 382.55 |
Capital Expenditures | -51.79 | -285.77 | -75.19 | -110.85 |
Other Investing Cash Flow Items Total | -310.47 | 90.93 | -61.02 | -200.55 |
Cashfrom Investing Activities | -362.25 | -194.84 | -136.21 | -311.40 |
Financing Cash Flow Items | -7.45 | -5.44 | -6.14 | -8.67 |
Issuance( Retirement)of Debt Net | -6.35 | -26.74 | -48.45 | -41.53 |
Cashfrom Financing Activities | -13.80 | -235.83 | -156.41 | -75.66 |
Foreign Exchange Effects | 0.00 | 0.00 | 0.00 | 0.00 |
Net Changein Cash | -17.57 | 20.24 | 37.38 | -4.51 |
Cash Interest Paid | 7.45 | 5.44 | 6.23 | 8.92 |
Cash Taxes Paid | 109.95 | 145.79 | 184.26 | 109.44 |
Total Cash Dividends Paid | - | -203.65 | -101.83 | -25.46 |
Suven Pharmaceuticals Dividend Suven Pharmaceuticals Bonus Suven Pharmaceuticals News Suven Pharmaceuticals AGM Suven Pharmaceuticals Rights Suven Pharmaceuticals Splits Suven Pharmaceuticals Board Meetings Suven Pharmaceuticals Key Metrics Suven Pharmaceuticals Shareholdings Suven Pharmaceuticals Profit Loss Suven Pharmaceuticals Balance Sheet Suven Pharmaceuticals Q1 Results Suven Pharmaceuticals Q2 Results Suven Pharmaceuticals Q3 Results Suven Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks